:,

Yuqi Tang1, Zhandong Qiu1, Yingyue Ding2

  • 1Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.

BMJ neurology open
|October 6, 2025
PubMed
概括

瘤活性脱髓化病变 (TDLs) 是多种多样的. 髓寡细胞糖蛋白 (MOG) 和N-甲基-D-酸受体 (NMDAR) 抗体会影响TDL患者的特征,但不会影响长期的结果.